Handelsbanken Fonder
ASND icon

Handelsbanken Fonder’s Ascendis Pharma A/S ASND Stock Holding History

Handelsbanken Fonder’s Portfolio ASND Stock Details ASND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.21M Buy
27,050
+11,583
+75% +$2.71M 0.02% 427
2026
Q1 		$3.54M Buy
15,467
+1,200
+8% +$269K 0.01% 561
2025
Q4 		$3.04M Buy
14,267
+700
+5% +$145K 0.01% 609
2025
Q3 		$2.7M Buy
13,567
+1,300
+11% +$242K 0.01% 634
2025
Q2 		$2.12M Buy
12,267
+700
+6% +$114K 0.01% 638
2025
Q1 		$1.8M Sell
11,567
-2,100
-15% -$300K 0.01% 690
2024
Q4 		$1.88M Sell
13,667
-4,000
-23% -$526K 0.01% 697
2024
Q3 		$2.64M Buy
17,667
+4,200
+31% +$567K 0.01% 575
2024
Q2 		$1.84M Buy
13,467
+1,200
+10% +$163K 0.01% 611
2024
Q1 		$1.85M Buy
12,267
+900
+8% +$128K 0.01% 626
2023
Q4 		$1.43M Hold
11,367
– – 0.01% 659
2023
Q3 		$1.06M Buy
11,367
+2,367
+26% +$221K 0.01% 701
2023
Q2 		$803K Buy
9,000
+500
+6% +$43.5K ﹤0.01% 829
2023
Q1 		$911K Buy
8,500
+1,400
+20% +$160K 0.01% 732
2022
Q4 		$867K Sell
7,100
-2,500
-26% -$290K 0.01% 703
2022
Q3 		$991K Hold
9,600
– – 0.01% 662
2022
Q2 		$892K Sell
9,600
-100
-1% -$9.43K 0.01% 733
2022
Q1 		$1.14M Hold
9,700
– – 0.01% 742
2021
Q4 		$1.3M Sell
9,700
-900
-8% -$134K 0.01% 774
2021
Q3 		$1.69M Buy
10,600
+1,300
+14% +$178K 0.01% 673
2021
Q2 		$1.22M Hold
9,300
– – 0.01% 812
2021
Q1 		$1.2M Sell
9,300
-1,000
-10% -$152K 0.01% 763
2020
Q4 		$1.72M Buy
10,300
+1,600
+18% +$265K 0.01% 637
2020
Q3 		$1.34M Hold
8,700
– – 0.01% 634
2020
Q2 		$1.29M Buy
+8,700
New +$1.19M 0.01% 618

Other funds holding ASND

RA Capital Management
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Avoro Capital Advisors
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Jupiter Topco
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Handelsbanken Fonder's ASND Position: Q2 2026 in Review

Handelsbanken Fonder increased its Ascendis Pharma A/S (ASND) stake by 75% in Q2 2026, buying an estimated $2.71M and bringing the position to 27,050 shares worth $7.21M. The position accounts for 0.02% of the portfolio, ranked #427.

Handelsbanken Fonder first reported a position in ASND in Q2 2020 and has held it in 25 quarters since. 313 funds tracked by Wall St. Rank hold ASND as of Q2 2026.

  • Handelsbanken Fonder held 27,050 shares of Ascendis Pharma A/S worth $7.21M as of Q2 2026.
  • Handelsbanken Fonder bought 11,583 Ascendis Pharma A/S shares in Q2 2026, an estimated $2.71M.
  • Ascendis Pharma A/S made up 0.02% of Handelsbanken Fonder's portfolio in Q2 2026, its #427 holding.
  • Handelsbanken Fonder first reported a position in Ascendis Pharma A/S in Q2 2020 and has held it in 25 quarters since.
  • 313 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2026.

Based on Handelsbanken Fonder's 13F filing for Q2 2026, filed 10 Jul 2026.